Pharmaceutical Composition Of S-Ketamine Hydrochloride

Patent No. EP2968221 (titled "Pharmaceutical Composition Of S-Ketamine Hydrochloride") was filed by Janssen Pharmaceutica on Mar 14, 2014. The application was issued on Jun 19, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ASPIRE PHARMAMar 18, 2020BROWN
SANDOZMar 17, 2020ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2968221

JANSSEN PHARMACEUTICA
Application Number
EP14719471A
Filing Date
Mar 14, 2014
Status
Revoked
May 7, 2021
Publication Date
Jun 19, 2019